Literature DB >> 28621642

Spectrum and antibiotic resistance of uropathogens between 2004 and 2015 in a tertiary care hospital in Hungary.

András Magyar1, Béla Köves1, Károly Nagy1, András Dobák2, Vinodh Kumar Adithyaa Arthanareeswaran1, Péter Bálint1, Florian Wagenlehner3, Péter Tenke1.   

Abstract

PURPOSE: Surveillance of the bacterial spectrum and antibiotic-resistance patterns of locally occurring uropathogens is essential to serve as a basis for empirical treatment of urinary tract infections (UTIs), as antibiotic-resistance rates may vary geographically with significant differences between countries and regions, and with time.
METHODOLOGY: We retrospectively analysed all urine samples taken in the department of urology in a tertiary care hospital in Hungary from January 2004 to December 2015.Results/Key findings. The five most commonly occurring bacteria were Escherichia coli, Enterococcus faecalis, Klebsiella pneumoniae, Pseudomonas aeruginosa and Proteus mirabilis. Resistance of Escherichia coli to ciprofloxacin increased significantly from 19 to 25 %. Although the resistance of Escherichia coli against cephalosporins showed an increasing trend, it still remained generally low. However, resistance rates of K. pneumoniae to cephalosporins were very high, reaching 60 %, due to the high rate of extended-spectrum-β-lactamase-positive Klebsiella strains. We observed a significant increase in the rate of carbapenem-resistant Pseudomonas aeruginosa.
CONCLUSION: Fluoroquinolones cannot be recommended for empirical treatment in our region. Cephalosporins can be a good empirical choice for treating Gram-negative UTIs, but should be avoided when multi-drug resistant (MDR) bacteria are suspected. Increases in the rate of carbapenem-resistant Pseudomonas aeruginosa, and in the general rate of MDR bacteria, are both a very alarming trend. We recommend practising prudent antibiotic policy, preferably using antibiotics with the narrowest possible spectrum.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28621642     DOI: 10.1099/jmm.0.000498

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  12 in total

1.  Differential epidemiology and antibiotic resistance of lactose-fermenting and non-fermenting Escherichia coli: Is it just a matter of taste?

Authors:  Márió Gajdács; Marianna Ábrók; Andrea Lázár; Katalin Burián
Journal:  Biol Futur       Date:  2020-06-04

2.  A Randomized Controlled Trial to Study the Rationale of Antibiotic Prophylaxis in Diagnostic Rigid Cystoscopy: A Relook in The Era of Antibiotic Stewardship.

Authors:  Harmandeep Singh Chahal; Shagun Sikka; Simran Kaur; Varun Mittal; Baldev Singh Aulakh; Sandeep Sharma
Journal:  Int J Appl Basic Med Res       Date:  2021-07-19

3.  Urogenital tuberculosis, the cause of ineffective antibacterial therapy for urinary tract infections.

Authors:  Ekaterina Kulchavenya; Andrey Cherednichenko
Journal:  Ther Adv Urol       Date:  2017-12-22

4.  In-Vitro Biofilm Formation and Antimicrobial Resistance of Escherichia coli in Diabetic and Nondiabetic Patients.

Authors:  Sunayana Raya; Ankit Belbase; Laxmi Dhakal; Krishna Govinda Prajapati; Reena Baidya; Nabin Kishor Bimali
Journal:  Biomed Res Int       Date:  2019-09-19       Impact factor: 3.411

5.  Characterization of Antibiotic-Susceptibility Patterns, Virulence Factor Profiles and Clonal Relatedness in Proteus mirabilis Isolates from Patients with Urinary Tract Infection in Iran.

Authors:  Arezoo Mirzaei; Mehri Habibi; Saeid Bouzari; Mohammad Reza Asadi Karam
Journal:  Infect Drug Resist       Date:  2019-12-27       Impact factor: 4.003

6.  Susceptibility of hospital-acquired uropathogens to first-line antimicrobial agents at a tertiary health-care hospital, Saudi Arabia.

Authors:  Abdulaziz Alamri; Bahaeldin Hassan; Mohamed E Hamid
Journal:  Urol Ann       Date:  2021-04-13

7.  Comparative Genomics of Antibiotic-Resistant Uropathogens Implicates Three Routes for Recurrence of Urinary Tract Infections.

Authors:  Robert Thänert; Kimberly A Reske; Tiffany Hink; Meghan A Wallace; Bin Wang; Drew J Schwartz; Sondra Seiler; Candice Cass; C A Burnham; Erik R Dubberke; Jennie H Kwon; Gautam Dantas
Journal:  mBio       Date:  2019-08-27       Impact factor: 7.867

8.  Comparative Epidemiology and Resistance Trends of Proteae in Urinary Tract Infections of Inpatients and Outpatients: A 10-Year Retrospective Study.

Authors:  Márió Gajdács; Edit Urbán
Journal:  Antibiotics (Basel)       Date:  2019-07-11

9.  Resistance Levels and Epidemiology of Non-Fermenting Gram-Negative Bacteria in Urinary Tract Infections of Inpatients and Outpatients (RENFUTI): A 10-Year Epidemiological Snapshot.

Authors:  Márió Gajdács; Katalin Burián; Gabriella Terhes
Journal:  Antibiotics (Basel)       Date:  2019-09-09

10.  Does the COVID Pandemic Modify the Antibiotic Resistance of Uropathogens in Female Patients? A New Storm?

Authors:  Cristian Mareș; Răzvan-Cosmin Petca; Aida Petca; Răzvan-Ionuț Popescu; Viorel Jinga
Journal:  Antibiotics (Basel)       Date:  2022-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.